Study of T Cells in Multiple Sclerosis Patients
Author Information
Author(s): Fritzsching Benedikt, Haas Jürgen, König Fatima, Kunz Pierre, Fritzsching Eva, Pöschl Johannes, Krammer Peter H., Brück Wolfgang, Suri-Payer Elisabeth, Wildemann Brigitte
Primary Institution: University Hospital of Heidelberg
Hypothesis
Is Treg dysfunction in MS patients limited to reduced control of peripheral T cell activation?
Conclusion
The study found low numbers of FOXP3+ T cells in MS brain lesions, while Treg were abundant in cerebrospinal fluid.
Supporting Evidence
- FOXP3+ T cells were detected in active lesions but were absent in 30% of biopsies.
- Treg were present in all CSF samples analyzed.
- Apoptosis-sensitive Treg were enriched in CSF compared to peripheral blood.
- Significant differences in Treg frequencies were observed between CSF and peripheral blood.
Takeaway
This study looked at special immune cells in the brains of people with multiple sclerosis and found that these cells are often missing from the lesions.
Methodology
The study used immunohistochemistry and six-color flow cytometry to analyze Treg in brain biopsies and cerebrospinal fluid from MS patients.
Potential Biases
Potential bias due to the selection of patients and the methods used for analysis.
Limitations
The study is limited by the small sample size and the focus on treatment-naïve patients.
Participant Demographics
Patients included 16 with brain biopsies and 17 with CSF samples, all newly diagnosed with relapsing-remitting MS.
Statistical Information
P-Value
0.019
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website